Demyelinating Disease Assessment
Demyelinating Disease Assessment is a clinical neurophysiological method that quantifies delayed visual evoked potential latencies to objectively detect and evaluate impaired neural conduction due to myelin loss in central nervous system disorders.
216
Publications
12.4K
Citations
1.3K
Authors
463
Institutions
Publications per year
2017–2026
52
Parents
216
D. W. Paty, Joël Oger, L. F. Kastrukoff et al. · Neurology · 1988 · 643 citations
Medicine, Neurology, Neuroscience +16
1–5 of 216
1.3K
5
h-index
5
h-index
University of California, San Francisco, United States
5 publications · 184 citations
5
h-index
5
h-index
4
h-index
1–5 of 1.3K
463
University College London
London, United Kingdom
10 h-index
51 publications
7.4K citations
National Hospital for Neurology and Neurosurgery
London, United Kingdom
9 h-index
42 publications
5.3K citations

Johns Hopkins University
Baltimore, United States
8 h-index
38 publications
3.8K citations

University of Toronto
Toronto, Canada
7 h-index
24 publications
1.3K citations
University of Pennsylvania
Philadelphia, United States
7 h-index
23 publications
1.8K citations

University of British Columbia
Vancouver, Canada
6 h-index
53 publications
10.3K citations

University of Genoa
Genoa, Italy
6 h-index
18 publications
571 citations
The University of Texas Southwestern Medical Center
Dallas, United States
5 h-index
10 publications
227 citations
1–8 of 463
20 publications · 2.2K citations
18
h-index
MSJ · 19 publications · 766 citations
17
h-index
Repository · 19 publications · 1.4K citations
13
h-index
11 publications · 674 citations
11
h-index
14 publications · 410 citations
11
h-index
1–5